Web Results

en.wikipedia.org/wiki/Bosentan

Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European ...

www.tracleer.com

What is TRACLEER® (bosentan)?. TRACLEER is a prescription medicine indicated for patients with certain types of pulmonary arterial hypertension (PAH, WHO ...

www.drugs.com/cdi/bosentan.html

Easy to read patient leaflet for Bosentan. Includes indications, proper use, special instructions, precautions, and possible side effects.

medlineplus.gov/druginfo/meds/a605001.html

Mar 15, 2017 ... Bosentan: learn about side effects, dosage, special precautions, and more on MedlinePlus.

reference.medscape.com/drug/tracleer-bosentan-342395

Medscape - Indication-specific dosing for Tracleer (bosentan), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

www.rxlist.com/tracleer-drug.htm

Sep 25, 2017 ... Learn about Tracleer (Bosentan) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related ...

phassociation.org/patients/treatments/bosentan

Apr 27, 2017 ... What is bosentan? Bosentan is an oral medication classified as an endothelin receptor antagonist (ERA) which is approved for the treatment of ...

dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=10355

Bosentan has a molecular weight of 569.64 and a molecular formula of C27H29 N5O6S•H2O. Bosentan is a white to yellowish powder. It is poorly soluble in ...

www.webmd.com/drugs/2/drug-22252/bosentan-oral/details

Find patient medical information for Bosentan Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.